Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: Drug loading and release properties

International Journal of Pharmaceutics

Volumn 410, Issue 1-2, 2011, Pages 118-124

  Zhang, Yanzhuo ^a   Zhang, Jinghai ^a   Jiang, Tongying ^a   Wang, Siling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Drug delivery; Drug loading; Enhanced dissolution; Mesocellular foam; Poorly water soluble drugs; Simvastatin

Indexed keywords

NANOPARTICLE; NITROGEN; POLYMER; SIMVASTATIN; SOLVENT; SURFACTANT; WATER;

ADSORPTION; ARTICLE; CRYSTAL; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG RELEASE; EVAPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLUID; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; CETRIMONIUM COMPOUNDS; CRYSTALLIZATION; NANOPARTICLES; PARTICLE SIZE; POLOXALENE; SIMVASTATIN; SOLUBILITY; SOLVENTS; SURFACE-ACTIVE AGENTS;

EID: 79955640333     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.07.040     Document Type: Article

References (38)

1. Ambike, A.A., Mahadik, K.R., Paradkar, A., 2005. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm. Res. 22, 990-998.
2. Ambrogi, V., Perioli, L., Marmottini, F., Giovagnoli, S., Esposito, M., Rossi, C., 2007. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. Eur. J. Pharm. Sci. 32, 216-222.
3. Barbé, C., Bartlett, J., Kong, L., Finnie, K., Lin, H.Q., Larkin, M., 2004. Silica particles: a novel drug-delivery system. Adv. Mater. 16, 1949-1966.
4. Cauda, V., Muhlstein, L., Onida, B., Bein, T., 2009. Tuning drug uptake and release rates through different morphologies and pore diameters of confined mesoporous silica. Microporous Mesoporous Mater. 118, 435-443.
5. Charnay, C., Bégu, S., Tourné-Péteilh, C., Nicole, L., Lerner, D.A., Devoisselle, J.M., 2004. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur. J. Pharm. Biopharm. 57, 533-540.
6. Chen, J.F., Ding, H.M., Wang, J.X., Shao, L., 2004. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25, 723-727. (Pubitemid 37357286)
7. Fu, Q., Rama Rao, G.V., Ista, L.K., Wu, Y., Andrzejewski, B.P., Sklar, L.A., 2003. Control of molecular transport through stimuli-responsive ordered mesoporous materials. Adv. Mater. 15, 1262-1266.
8. Graeser, K.A., Strachan, C.J., Patterson, J.E., Gordon, K.C., Rades, T., 2008. Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin. Cryst. Growth Des. 8, 128-135.
9. Gursoy, R.N., Benita, S., 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drug. Biomed. Pharmacother. 58, 173-182.
10. He, Q.J., Zhang, J.M., Shi, J.L., Zhu, Z.Y., Zhang, L.X., Bu, W.B., Guo, L.M., Chen, Y., 2010. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 31, 1085-1092.
11. Heikkilä, T., Salonen, J., Tuura, J., Hamdy, M.S., Mul, G., Kumar, N., Salmi, T., Murzin, D.Y., Laitinen, L., Kaukonen, A.M., Hirvonen, J., Lehto, V.P., 2007. Mesoporous silica material TUD-1 as a drug delivery system. Int. J. Pharm. 331, 133-138.
12. Horcajada, P., Rámila, A., Pérez-Pariente, J., Vallet-Regi, M., 2004. Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater. 68, 105-109. (Pubitemid 38265756)
13. Kapoor, S., Hegde, R., Bhattacharyya, A.J., 2009. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release. J. Control. Release 140, 34-39.
14. Katiyar, A., Yadav, S., Smirniotis, P.G., Pinto, N.G., 2006. Synthesis of ordered large pore SBA-15 spherical particles for adsorption of biomolecules. J. Chromatogr. A 1122, 13-20. (Pubitemid 44041353)
15. Kesisoglou, F., Panmai, S., Wu, Y., 2007. Nanosizing - oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59, 631-644.
16. Kresge, C.T., Leonowicz, M.E., Roth, W.J., Vartuli, J.C., Beck, J.S., 1992. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359, 710-712. (Pubitemid 23589384)
17. Lettow, J.S., Han, Y.J., Schmidt-Winkel, P., Yang, P., Zhao, D., Stucky, G.D., Ying, J.Y., 2000. Hexagonal to mesocellular foam phase transition in polymer-templated mesoporous silicas. Langmuir 16, 8291-8295.
18. Li, Y.J., Zhou, G.W., Li, C.J., Qin, D.W., Qiao, W.T., Chu, B., 2009. Adsorption and catalytic activity of Porcine pancreatic lipase on rod-like SBA-15 mesoporous material. Colloids Surf. A 341, 79-85.
19. Lin, Y.S., Tsai, C.P., Huang, H.Y., Kuo, C.T., Hung, Y., Huang, D.M., Chen, Y.C., Mou, C.Y., 2005. Well-ordered mesoporous silica nanoparticles as cell markers. Chem. Mater. 17, 4570-4573.
20. Lipinski, C.A., 2002. Poor aqueous solubility - an industry wide problem in drug discovery. Am. Pharm. Rev. 53, 82-85.
21. Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting. Adv. Drug Deliv. Rev. 46, 3-26.
22. Mal, N.K., Fujiwara, M., Tanaka, Y., 2003. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 421, 350-353. (Pubitemid 36157928)
23. Mellaerts, R., Mols, R., Jammaer, J.A.G., Aerts, C.A., Annaert, P., Humbeeck, J.V., Mooter, G.V., Augustijns, P., Martens, J.A., 2008. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur. J. Pharm. Biopharm. 69, 223-230.
24. Qu, F.Y., Zhu, G.S., Huang, S.Y., Li, S.G., Sun, J.Y., Zhang, D.L., Qiu, S.L., 2006. Controlled release of captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater. 92, 1-9.
25. Sachs-Barrable, K., Lee, S.D., Wasan, E.K., Thornton, S.J., Wasan, K.M., 2008. Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections. Adv. Drug Deliv. Rev. 60, 692-701.
26. Salonen, J., Laitinen, L., Kaukonen, A.M., Tuura, J., Björkqvist, M., Heikkilä, T., Vähä-Heikkilä, K., Hirvonen, J., Lehto, V.-P., 2005. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control. Release 108, 362-374. (Pubitemid 41608668)
27. Schmidt-Winkel, P., Lukens, W.W., Zhao, D., Yang, P., Chmelka, B.F., Stucky, G.D., 1999. Mesocellular siliceous foams with uniformly sized cells and windows. J. Am. Chem. Soc. 121, 254-255.
28. Slowing, I.I., Trewyn, B.G., Giri, S., Lin, V.S.-Y., 2007. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv. Funct. Mater. 17, 1225-1236.
29. Song, S.W., Hidajat, K., Kawi, S., 2005. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. Langmuir 21, 9568-9575. (Pubitemid 41507008)
30. Thomas, M.J.K., Slipper, I., Walunj, A., Jain, A., Favretto, M.E., Kallinteri, P., Douroumis, D., 2009. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. Int. J. Pharm. 387, 272-277.
31. Vasconcelos, T., Sarmento, B., Costa, P., 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 12, 1068-1075. (Pubitemid 350186132)
32. Wang, S., 2009. Ordered mesoporous materials for drug delivery. Microporous Mesoporous Mater. 117, 1-9.
33. Wong, S.M., Kellaway, I.W., Murdan, S., 2006. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int. J. Pharm. 317, 61-68.
34. Wu, Z., Jiang, Y., Kim, T., Lee, K., 2007. Effects of surface coating on the controlled release of vitamin B1 from mesoporous silica tablets. J. Control. Release 119, 215-221. (Pubitemid 46759558)
35. Yang, P.P., Quan, Z.W., Lu, L.L., Huang, S.S., Lin, J., 2008. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Biomaterials 29, 692-702. (Pubitemid 350181037)
36. Yu, H., Zhai, Q.Z., 2009. Mesoporous SBA-15 molecular sieve as a carrier for controlled release of nimodipine. Microporous Mesoporous Mater. 123, 298-305.
37. Zhang, F., Aaltonen, J., Tian, F., Saville, D.J., Rades, T., 2009. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin. Eur. J. Pharm. Biopharm. 71, 64-70.
38. Zhao, D.Y., Feng, J.L., Huo, Q.S., Melosh, N., Fredrickson, G.H., Chmelka, B.F., Stucky, G.D., 1998. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279, 548-552. (Pubitemid 28067280)